Effect of Rifampin Therapy on Thyroid Function Tests in a Hypothyroid Patient on Replacement L-Thyroxine

  1. WILLIAM L. ISLEY, M.D.
  1. University of Missouri-Kansas City School of Medicine,
    Kansas City, Missouri

    Excerpt

    Normal volunteers treated with rifampin, a potent inducer of liver microsomal enzymes, have significant decreases in serum thyroxine levels and free thyroxine index but no changes in basal or stimulated thyrotropin levels (1-3). We report the case of a patient with primary hypothyroidism receiving a constant replacement dose of L-thyroxine who developed biochemical hypothyroidism when treated with rifampin.

    A 31-year-old woman with Turner syndrome and hypertension was admitted with dizziness, nausea, and vomiting. Fifteen months earlier she had had a total thyroidectomy for a rapidly enlarging goiter, which was complicated by hypoparathyroidism and recurrent laryngeal nerve palsy. Pathologic examination of

    This 100-word excerpt has been provided in the absence of an abstract.

    Acknowledgments

    ACKNOWLEDGMENTS: The author thanks Jeanne Sarkis, M. L.S. for help in the literature research; the University of Missouri-Kansas City School of Medicine Endocrine Laboratory for performance of hormone assays; Dr. Larry Dall for encouragement and advice; and Ms. Ora Stafford-Clarke for secretarial assistance.

    Article and Author Information

    • ▸Requests for reprints should be addressed to William L. Isley, M.D.; University of Missouri-Kansas City School of Medicine (Gold 5), 2411 Holmes; Kansas City, MO 61408.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement